BP061

Cefalexin

British Pharmacopoeia (BP) Reference Standard

• 동의어(들): 7-(D-α-amino-phenylacetamido)-3-methyl-3-cepheme-4-carboxylic acid
• 실험식(Hill 표기법): C₁₆H₁₇N₃O₄S
• CAS Number: 15686-71-2
• Molecular Weight: 347.39
• EC Number: 239-773-6
• MDL number: MFCD00056877
• UNSPSC 코드: 41116107
• NACRES: NA.24

속성

• Grade: pharmaceutical primary standard
• API family: cefalexin
• 형태: powder
• 유통기한: limited shelf life, expiry date on the label
• 제조업체/상표: BP
• 응용 분야: pharmaceutical; pharmaceutical small molecule
• 형식: neat
• 저장 온도: 2-8°C
• SMILES string: N[C@@H](C(N[C@@H]1C(N2[C@]1([H])SCC(C)=C2C(O)=O)=O)=O)C3=CC=CC=C3
• InChI: 1S/C16H17N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1
• InChI key: ZAIPMKNFIOOWCQ-UEKVPHQBSA-N

설명

일반 설명

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

애플리케이션

Cefalexin BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Cefalexin Oral Suspension

Cefalexin Capsules

Cefalexin Tablets

Cefradine Oral Suspension

Cefradine Capsules

Cefradine Injection

포장

Unit quantity: 150 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

기타 정보

Sales restrictions may apply.

안전성 정보

• 픽토그램: GHS08
• 신호어: Danger
• 유해 및 위험 성명서: H317,H334
• 예방조치 성명서: P261 - P272 - P280 - P284 - P302 + P352 - P333 + P313
• Hazard Classifications: Resp. Sens. 1 - Skin Sens. 1
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 1